Ellen J Kim Selected Research

Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)

5/2022	Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
1/2022	Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.
8/2021	Chlormethine Gel for the Treatment of Skin Lesions in All Stages of Mycosis Fungoides Cutaneous T-Cell Lymphoma: A Narrative Review and International Experience.
5/2021	The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
1/2021	Lack of Systemic Absorption of Topical Mechlorethamine Gel in Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
1/2021	Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome.
9/2020	Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumab.
1/2018	Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
10/2017	Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma.
10/2015	The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ellen J Kim Research Topics

Disease

26	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 05/2022 - 07/2003
16	Mycosis Fungoides 05/2022 - 04/2008
8	Lymphoma (Lymphomas) 01/2022 - 02/2011
5	Neoplasms (Cancer) 09/2021 - 04/2005
4	Hematologic Diseases (Blood Diseases) 01/2021 - 04/2008
3	Pruritus (Itching) 05/2015 - 10/2010
2	Skin Diseases (Skin Disease) 05/2022 - 04/2008
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 09/2009
2	Atopic Dermatitis (Atopic Eczema) 09/2020 - 05/2015
2	Sarcoidosis (Schaumann Disease) 01/2017 - 05/2013
2	Sezary Syndrome (Sezary Erythroderma) 02/2012 - 12/2011
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 09/2008 - 03/2005
1	Parapsoriasis 05/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Bronchopneumonia 01/2018
1	Cellulitis 01/2018
1	Fever (Fevers) 01/2018
1	Pulmonary Embolism 01/2018
1	Polymyositis 01/2018
1	Sepsis (Septicemia) 01/2018
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 10/2016
1	Hypothyroidism 10/2015
1	Dyslipidemias (Dyslipidemia) 10/2015
1	Inflammation (Inflammations) 09/2015
1	Lymphadenopathy 01/2015
1	Exfoliative Dermatitis (Erythroderma) 01/2015
1	Edema (Dropsy) 09/2014
1	Progressive Multifocal Leukoencephalopathy 08/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2013
1	Ulcer 12/2011
1	Heart Failure 09/2011
1	Dermatomyositis (Dermatopolymyositis) 07/2010
1	Arthritis (Polyarthritis) 07/2010
1	Vasculitis (Vasculitides) 07/2010
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 09/2009
1	Bullous Pemphigoid (Pemphigoid) 09/2009
1	Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) 02/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2008
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 04/2007

Drug/Important Bio-Agent (IBA)

7	Mechlorethamine (Nitrogen Mustard)FDA Link 05/2022 - 01/2013
3	Brentuximab VedotinIBA 01/2021 - 08/2014
3	Bexarotene (LGD1069)FDA Link 01/2021 - 03/2005
3	Vorinostat FDA Link 01/2018 - 09/2009
3	CytokinesIBA 09/2015 - 04/2005
3	romidepsin (FK228)FDA Link 01/2015 - 10/2010
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2017
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 10/2016
2	Monoclonal AntibodiesIBA 01/2018 - 08/2014
2	Carmustine (FIVB)FDA Link 10/2017 - 01/2013
2	Prostaglandins AIBA 01/2017 - 05/2013
2	Pharmaceutical PreparationsIBA 08/2014 - 02/2012
2	Interferon alpha-2 (Roferon-A)FDA Link 09/2011 - 03/2005
1	AntigensIBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Ointments (Pastes)IBA 01/2021
1	dupilumabIBA 09/2020
1	AT 61IBA 01/2018
1	mogamulizumabIBA 01/2018
1	vasectrin IIIIBA 01/2018
1	CC ChemokinesIBA 01/2018
1	RetinoidsIBA 10/2015
1	resiquimodIBA 09/2015
1	InterleukinsIBA 05/2015
1	Coloring Agents (Dyes)IBA 09/2014
1	Therapeutic UsesIBA 06/2013
1	Dasatinib (BMS 354825)FDA Link 05/2013
1	Indicators and Reagents (Reagents)IBA 02/2013
1	SteroidsIBA 02/2013
1	Histamine Antagonists (Antihistamines)IBA 02/2013
1	Histone Deacetylase InhibitorsIBA 02/2012
1	Acyclovir (Aciclovir)FDA LinkGeneric 12/2011
1	Cidofovir (Vistide)FDA Link 12/2011
1	Ficusin (Psoralen)IBA 07/2011
1	Etanercept (Enbrel)FDA Link 07/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010
1	Tumor Necrosis Factor InhibitorsIBA 07/2010
1	Adalimumab (Humira)FDA Link 07/2010
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 02/2009
1	InterferonsIBA 09/2008
1	Retinoid X Receptor alphaIBA 09/2008
1	denileukin diftitox (Ontak)FDA Link 04/2007

Therapy/Procedure

20	Therapeutics 05/2022 - 04/2005
3	Photopheresis 05/2017 - 07/2003
2	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2009
2	Stem Cell Transplantation 09/2015 - 04/2008
2	Drug Therapy (Chemotherapy) 08/2014 - 01/2013
2	Immunomodulation 12/2011 - 07/2003
1	Immunotherapy 05/2017
1	Radiotherapy 10/2016
1	Aftercare (After-Treatment) 06/2013
1	Transplantation 04/2008